[go: up one dir, main page]

WO2003018840A1 - Evaluation du niveau de cancerisation d'un prelevement mammalien - Google Patents

Evaluation du niveau de cancerisation d'un prelevement mammalien Download PDF

Info

Publication number
WO2003018840A1
WO2003018840A1 PCT/JP2002/008161 JP0208161W WO03018840A1 WO 2003018840 A1 WO2003018840 A1 WO 2003018840A1 JP 0208161 W JP0208161 W JP 0208161W WO 03018840 A1 WO03018840 A1 WO 03018840A1
Authority
WO
WIPO (PCT)
Prior art keywords
canceration
mammal
specimen
origin
degree
Prior art date
Application number
PCT/JP2002/008161
Other languages
English (en)
French (fr)
Inventor
Toshikazu Ushijima
Kazuaki Miyamoto
Original Assignee
Sumitomo Chemical Company, Limited
Japan As Represented By President Of National Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Company, Limited, Japan As Represented By President Of National Cancer Center filed Critical Sumitomo Chemical Company, Limited
Priority to EP02755897A priority Critical patent/EP1426449A4/en
Priority to US10/487,219 priority patent/US20050064412A1/en
Priority to AU2002323945A priority patent/AU2002323945B2/en
Priority to CA002458182A priority patent/CA2458182A1/en
Publication of WO2003018840A1 publication Critical patent/WO2003018840A1/ja

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00Reactions characterised by treatment of reaction samples
    • C12Q2523/10Characterised by chemical treatment
    • C12Q2523/125Bisulfite(s)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PCT/JP2002/008161 2001-08-23 2002-08-09 Evaluation du niveau de cancerisation d'un prelevement mammalien WO2003018840A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP02755897A EP1426449A4 (en) 2001-08-23 2002-08-09 METHOD FOR EVALUATING THE LEVEL OF CANCERIZATION OF A PREPARATION FROM MAMMALS
US10/487,219 US20050064412A1 (en) 2001-08-23 2002-08-09 Method of evaluating degree of canceration of mammal-origin specimen
AU2002323945A AU2002323945B2 (en) 2001-08-23 2002-08-09 Method of evaluating degree of canceration of mammal-origin specimen
CA002458182A CA2458182A1 (en) 2001-08-23 2002-08-09 Method for assessing cancerous state of mammal-derived specimen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-252804 2001-08-23
JP2001252804 2001-08-23

Publications (1)

Publication Number Publication Date
WO2003018840A1 true WO2003018840A1 (fr) 2003-03-06

Family

ID=19081221

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/008161 WO2003018840A1 (fr) 2001-08-23 2002-08-09 Evaluation du niveau de cancerisation d'un prelevement mammalien

Country Status (5)

Country Link
US (1) US20050064412A1 (ja)
EP (1) EP1426449A4 (ja)
AU (1) AU2002323945B2 (ja)
CA (1) CA2458182A1 (ja)
WO (1) WO2003018840A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004018668A1 (ja) * 2002-08-23 2004-03-04 Sumitomo Chemical Company, Limited ヒト由来の検体の癌化度を評価する方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999022005A2 (en) * 1997-10-24 1999-05-06 Massachusetts Institute Of Technology Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040033490A1 (en) * 2000-03-31 2004-02-19 Laird Peter W. Epigenetic sequences for esophageal adenocarcinoma
US6893820B1 (en) * 2001-01-31 2005-05-17 The Ohio State University Research Foundation Detection of methylated CpG rich sequences diagnostic for malignant cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999022005A2 (en) * 1997-10-24 1999-05-06 Massachusetts Institute Of Technology Heparan sulfate d-glucosaminyl 3-o-sulfotransferases, an uses therefor

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
See also references of EP1426449A4 *
SHWORAK NICHOLAS W. ET AL.: "Multiple isoforms of heparan sulfate D-glucosaminyl 3-omicron-sulfotransferase", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 8, 1999, pages 5170 - 5184, XP002958904 *
ZOCHBAUER-MULLER S. ET AL.: "5' CpG Island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast", CANCER RES., vol. 61, no. 9, 2001, pages 3581 - 3585, XP002958905 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004018668A1 (ja) * 2002-08-23 2004-03-04 Sumitomo Chemical Company, Limited ヒト由来の検体の癌化度を評価する方法

Also Published As

Publication number Publication date
CA2458182A1 (en) 2003-03-06
AU2002323945B2 (en) 2008-08-07
EP1426449A1 (en) 2004-06-09
EP1426449A4 (en) 2004-10-13
US20050064412A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
AU4205299A (en) Method and apparatus for determining preexisting stresses based on indentation or other mechanical probing of the material
WO2002103618A8 (en) Statistical model
AU2002333834A1 (en) System, method and computer program for conducting optical transmission measurements and evaluating determined measuring variables
WO2007038754A3 (en) Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
WO2003001167A3 (en) Permittivity based temperature measurement and related methods
WO2004013723A3 (en) Model and parameter selection for optical metrology
CA2434132A1 (en) Method for magnetic resonance fluid characterization
CA2405141A1 (en) Detecting errors in the determination of magnetic location or orientation
EP0997731A3 (en) Method for evaluating the quality of the bonding between two metal pipes
EP1398759A3 (en) Systems and methods for determining the N-best strings of an automaton
EP1318698A3 (en) Microwave oven comprising an environmental sensor and dealing with the behavior of this sensor
WO2003091695A3 (en) Identification of biomarkers for detecting prostate cancer
WO2004015420A8 (en) Method for diagnosing multiple sclerosis
WO2003018840A1 (fr) Evaluation du niveau de cancerisation d'un prelevement mammalien
WO2002099982A3 (en) Methods for improving signal detection from an array
WO2003062800A3 (en) Portable system and method for determining one or more reflectance properties of a surface
WO2004061419A3 (en) Systems and methods for estimating properties of a sample
WO2007005881A3 (en) Calibration system for use with lateral flow assay test strips
CA2390497A1 (en) Method for nondestructively determining aged deterioration accompanying change in brittleness of ferromagnetic struction materials
EP1058104A3 (en) Measurement of transmission oil pressure by monitoring solenoid current
CA2195527A1 (en) Sampled-Continuous Probability Method of Velocity Measurement of the Object Having Informatively-Structural Inhomogeneity
WO2003019556A3 (en) Method and apparatus for selecting equalization targets
WO2004014066A3 (en) Method and devic the for setting the slice level in a binary signal
AU7490394A (en) Measuring section for an electromagnetic flowmeter and a method for the manufacture thereof
EP1679371A4 (en) METHOD FOR ASSESSING THE CROSSING GRADE

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS KE KG KR KZ LC LR LS LT LU LV MA MD MG MK MN MX MZ NO NZ OM PH PL PT RO RU SE SG SI SK SL TJ TM TN TR TT TZ UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10487219

Country of ref document: US

Ref document number: 2458182

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002323945

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2002755897

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2002755897

Country of ref document: EP